Accelerating Discovery

Through a Better Platform

Our proprietary software platform supports the rapid discovery, iteration, and evaluation of new behavioral therapeutics targeting diseases caused or complicated by poor quality nutrition.

2022
BT-001 Pivotal Clinical Trial Design
A Peer Reviewed Rationale and Design Manuscript. Clinical Cardiology, 2022.
2020
A Software Application Delivering Behavioral Therapy Improved Glycemic Control in Adults With Type 2 Diabetes
A Peer Reviewed Study. Journal of the Endocrine Society, 2020.
2020
Impact of Nutritional CBT Delivered by a Mobile Application in Adults with Type 2 Diabetes
Pilot Study Findings.
2019
Estimating the impact of novel digital therapeutics in type 2 diabetes and hypertension: Health economic analysis
A Peer Reviewed Study. Journal of Medical Internet Research, 2019.
2019
Digital Biomarkers and Their Potential to Increase Treatment Efficacy
A Peer Reviewed Study. British Medical Journal, 2019.
2019
Estimating the Economic Impact of Novel Digital Therapeutics in Type 2 Diabetes and Hypertension
Poster Presentation at IPSOR 2019 Conference
2019
Achieving Rapid Blood Pressure Control With Digital Therapeutics: Retrospective Cohort and Machine Learning Study
A Peer Reviewed Study. Journal of Medical Internet Research, 2019.
2018
Change in Glycemic Control With Use of a Digital Therapeutic in Adults With Type 2 Diabetes: Cohort Study
A Peer Reviewed Study. Journal of Medical Internet Research, 2018.

Top-Line Results from Pivotal Trial of BT-001, 2022

Positive primary and secondary endpoint data from pivotal clinical trial for type 2 diabetes digital therapeutics.

Learn More

Pilot Data Presented at Endocrine 2020

This study represents an important milestone on the path to regulatory approval, demonstrating that a software-only product configuration delivering behavioral therapy can produce meaningful outcomes in patients.

Have a question or want to learn more? Get in touch and let us know what's on your mind.

Get In Touch

Accelerating Discovery

Through a Better Platform

BT-001 Pivotal Clinical Trial Design

A Software Application Delivering Behavioral Therapy Improved Glycemic Control in Adults With Type 2 Diabetes

Impact of Nutritional CBT Delivered by a Mobile Application in Adults with Type 2 Diabetes

Estimating the impact of novel digital therapeutics in type 2 diabetes and hypertension: Health economic analysis

Digital Biomarkers and Their Potential to Increase Treatment Efficacy

Estimating the Economic Impact of Novel Digital Therapeutics in Type 2 Diabetes and Hypertension

Achieving Rapid Blood Pressure Control With Digital Therapeutics: Retrospective Cohort and Machine Learning Study

Change in Glycemic Control With Use of a Digital Therapeutic in Adults With Type 2 Diabetes: Cohort Study